Allergic rhinoconjunctivitis;Allergische rhinokonjunktivitis

Allergo Journal

Volumn 12, Issue 3, 2003, Pages 182-194

  Bachert, Claus ^a   Borchard, Ulrich ^b   Wedi, Bettina ^b   Klimek, Lothor ^b   Rasp, Gerd ^b   Riechelmann, Herbert ^b   Schultze Werninghaus, Gerhard ^b   Wahn, Ulrich ^b   Ring, Johannes ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Allergic Rhinitis; Classification; Diagnosis; Therapy

Indexed keywords

ALLERGIC RHINITIS; COMORBIDITY; DISEASE CLASSIFICATION; IMMUNOTHERAPY; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RHINOCONJUNCTIVITIS;

EID: 0038732572     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Adelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, Byrne A, Champain K, Thirlwell J, Cioppa GD, Sandstrom T. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106: 253-9
2. Bachert C. The role of histamine in allergic disease: reappraisal of its inflammatory potential. Allergy 2002; 57: 287-96
3. Bachert C, Berdel D, Enzmann H, Fuchs E, Gonsior E, Hofmann D, Keller H, Nitz U, Rudolph R, Rüdiger W, Schlenter WW. Richtlinien für die Durchführung von nasalen Provokationtests mit Allergenen bei Erkrankungen der oberen Luftwege. Allergologie 1990; 2: 53-5
4. Bachert C, Hörmann K, Mösges R, Rasp G, Riechelmann H, Müller R, Luckhaupt H, Stuck BA, Rudack C. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003; 58: accepted
5. Bachert C, die Konsensusgruppe. Die nasale Hyperreaktivität - die allergische Rhinitis und ihre Differential-diagnosen. Allergologie 1997; 20: 39-52
6. Blair H, Herbert RL. Treatment of seasonal allergic rhinitis with 2 percent sodium cromoglycate (BP) solution. Clin Allergy 1973; 3: 283-8
7. Bolger WE, Kennedy DW. Nasal endoscopy in the outpatient clinic. Otolaryngol Clin North Am 1992; 25: 791-802
8. Bonsmann U, Bachert C, Delank KW, Rohdewald P. Presence of fluticasone propionate on human nasal mucosal surface and in human nasal tissue over a period of 24 h after intranasal application. Allergy 2001; 56: 532-5
9. 1-Antihistaminika im Vergleich. Allergologie 2003; 26: 24-32.
10. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Ouestionnaire. J Allergy Clin Immunol 1994; 94: 182-8
11. Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, Fokkens W, Lockey R, Meltzer EO, Mullol J, Naclerio RM, Price D, Simons FE, Vignola AM, Warner JO. Requirements for medications commonly used in the treatment of allergic rhinits. Allergy 2003; 58: 192-7
12. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group.; World Health Organization. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001; 108: S147-334
13. Bousquet J, Chanal I, Alquié MC, Charpin D, Didier A, Germouty J, Greillier P, Ickovic MH, Maria Y, Montané F, Perrin-Fayolle M, Seignalet C, Severac JC, Vergnenègre A, Aubert B, Bons J. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993; 48: 327-33
14. Bousquet J, Lockey R, Malling H. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44): 1-42
15. Brown JL, Frew AJ. The efficacy of oromucosal immunotherapy in respiratory allergy. Clin Exp Allergy 2001; 31: 8-10
16. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983; 16: 87-101
17. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB Jr, Adelman DC. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997; 100: 110-21
18. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995; 96: 971-9
19. Ciprandi G, Ricca V, Tosca M, Landi M, Passalacqua G, Canonica GW. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. Allergy 1999; 54: 358-65
20. Connell JT. Ouantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy 1969; 43: 33-44
21. Corey JP, Adham RE, Abbass AH, Seligman I. The role of IgE-mediated hypersensitivity in otitis media with effusion. Am J Otolaryngol 1994; 15: 138-44
22. Corren J, Harris AG, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, Chen R, Chervinsky P, Cohen R, Fourre J, Grossman J, Meltzer E, Pedinoff A, Stricker W, Wanderer A. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997; 100: 781-8
23. Craig S, Rubinstein E, Reisman RE, Arbesman CE. Treatment of ragweed hay fever with intranasally administered disodium cromoglycate. Clin Allergy 1977; 7: 569-76
24. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998; 101: 633-7
25. Davies A, Lewith G, Goddard J, Howarth P. The effect of acupuncture on nonallergic rhinitis: a controlled pilot study. Altern Ther Health Med 1998; 4: 70-4
26. Des Roches A, Paradis L, Knani J, Hejjajoui A, Dhivert H, Chanez P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of efficacy of immunotherapy after its cessation. Allergy 1996; 51: 430-3
27. Dolovich J, Kennedy L, Vickerson F, Kazim F. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide. J Allergy Clin Immunol 1987; 80: 274-8
28. Donahue JG, Greineder DK, Connor-Lacke L, Canning CF, Platt R. Utilization and cost of immunotherapy for allergic asthma and rhinitis. Ann Allergy Asthma Immunol 1999; 82: 339-47
29. Dorsch W, Ring J. Komplementärmethoden bzw. so genannte Alternativmethoden in der Allergologie. Allergo J 2002; 11: 163-170
30. Dreborg S. The skin prick test in the diagnosis of atopic allergy. J Am Acad Dermatol 1989; 21: 820-1
31. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992; 90: 135-8
32. Fisher WG. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy 1994; 73: 515-20
33. Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997; 10: 361-6
34. Goldschmidt O, Mösges R, Klimek L, Hauswald B, Schapowal A. Die Reaktion der Nasenschleimhaut bei gesunden Probanden auf Histaminprovokation. Allergologie 1998; 21: 141-9
35. Graf P, Hallen H, Juto JE. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngol 1995; 115: 71-5
36. Hansen B, Mygind N. How often do normal persons sneeze and blow the nose? Rhinology 2002; 40: 10-2
37. Holopainen E, Backman A, Salo OP. Effect of disodium cromoglycate on seasonal allergic rhinitis. Lancet 1971; 1: 55-7
38. Horak F, Toth J, Marks B, Stubner UP, Berger UE, Jager S, Burtin B, Duby C. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy 1998; 53: 849-56
39. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhino-conjunctivitis. Clin Exp Allergy 1991; 21: 77-83
40. Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Roszko P, Zegarelli E, Wood CC. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol 1995; 95: 1128-32
41. Keith PK, Conway M, Evans S, Wong DA, Jordana G, Pengelly D, Dolovich J. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994; 93: 567-74
42. Kersten W, Wahl P-G von, Lange CE, Wenning J. Empfehlungen zur In-vitro-Diagnostik allergischer Erkrankungen. Allergo J 2000; 9: 21-6
43. Kleine-Tebbe J, Fuchs T, Klimek L, Kuhr J, Lepp U, Niggemann B, Rakoski J, Renz H, Saloga J, Simon J. Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen. Allergo J 2000; 9: 317-24
44. Klimek L. Allergenkarenz. In: Klimek L, Riechelmann H, Saloga J, Mann W, Knop J, Hrsg. Allergologie und Umweltmedizin. Stuttgart: Schattauer-Verlag, 1997
45. Klimek L, Reichenbach M, Mewes T, Mann W. Untersuchungen zur Reproduzierbarkeit und jahreszeitlichen Abhängigkeit von spezifischen intranasalen Provokationstests bei Birkenpollenallergikern. Laryngorhinootologie 1997; 76: 475-9
46. Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Berg A von, Leupold W, Bergmann KC, Rolinck-Werninghaus C, Grave M, Hultsch T, Wahn U. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109: 274-80
47. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 2001; 108: (Suppl 1): S9-15
48. Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients. Allergy 1987; 42: 168-72
49. Leino M, Carlson C, Jaanio E, Koivunen T, Lavikkala H, Riihela K, Takalo E. Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis. Ann Allergy 1990; 64: 398-402
50. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104: 301-4
51. Malm L, Gerth van Wijk R, Bachert C. Guidelines for nasal provocations with aspects on nasal patency, air-flow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology 2000; 38: 1-6
52. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111: 170-3
53. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105: 917-22
54. Merget R, Schultze-Werninghaus G: Allerglehauttest trotz antiallergischer Therapie. Dtsch Med Wochenschr 1983; 108: 1250-3
55. Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS, Nolop K, Lutsky B, Durham SR, Hamid O. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-54
56. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-6
57. Mori S, Fujieda S, Igarashi M, Fan GK, Saito H. Submucous turbinectomy decreases not only nasal stiffness but also sneezing and rhinorrhea in patients with perennial allergic rhinitis. Clin Exp Allergy 1999; 29: 1542-8
58. Mygind N, Laursen, Dahl R. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common, but poorly understood therapy. Allergy 2000; 55: 11-5
59. Neumann Y, Bullinger M, Przybilla B. Quality of life in allergic rhinitis: standardisation of a self-assessment questionnaire. Allergy 1992; 47 (Suppl 12): 72 (Abstract)
60. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31: 392-7
61. Pariente PD, LePen C, Los F, Bousquet J. Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 1997; 12: 585-95
62. Passalacqua G, Albano M, Canonica GW, Bachert C, Cauwenberge P van, Davies RJ, Durham SR, Kontou-Fili K, Horak F, Malling HJ. Inhaled and nasal corticosteroids: safety aspects. EAACI Position Paper. Allergy 2000; 55: 16-33
63. Pichler CE, Helbling A, Pichler WJ. Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 2001; 56: 301-6
64. Pullerits T, Praks L, Skoogh BE, Ani R, Lotvall J. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999; 159: 1814-8
65. Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S, Ricciardi L. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31: 1295-302
66. Rachelefsky G, Chervinsky P, Meltzer E, Morris R, Seltzer J, Skoner D. An evaluation of the effects of beclomethasone dipropionate on long-term growth in children. J Allergy Clin Immunol 1998; 101: 236 (Abstract)
67. Renz H, Becker W-M, Bufe J, Kleine-Tebbe J, Raulf-Heimsoth M, Saloga J, Werfel T, Worm M. In-vitro-Allergie-diagnostik. Positionspapier der DGAI. Allergo J 2002; 11: 492-506
68. Riechelmann H. Umweltmedizin in der HNO-Heilkunde. Laryngorhinootologie 2000; 79: 100-27
69. Riechelmann H. Klinische Differentialdiagnose der chronischen Rhinopathie. Allergo J 2001; 10: 386-95
70. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter W, Tasman A, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege - Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (Sektion HNO) gemeinsam mit der Arbeitsgemeinschaft Klinische Immunologie, Allergologie und Umweltmedizin der Deutschen Gesellschaft für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie. Allergo J 2002; 11: 29-36
71. Ring J, Wenning J. Weißbuch: Allergie in Deutschland 2000. Deutsche Gesellschaft für Allergologie und klinische Immunologie. München: Urban & Vogel, 2000
72. Ruhno J, Denburg J, Dolovich J. Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis. J Allergy Clin Immunol 1988; 81: 570-4
73. Ruoppi P, Seppa J, Nuutinen J. Acute frontal sinusitis: etiological factors and treatment outcome. Acta Otolaryngol 1993; 113: 201-5
74. Schata M, Jorde W, Richarz-Barthauer U. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1991; 87: 873-8
75. Sennekamp J, Fuchs T, Hornung B, Kersten W, Klimek L, Leupold W, Merk H, Rebien W. Empfehlungen zur praktischen Durchführung der spezifischen Immuntherapie mit Allergenen (Hyposensibilisierung). Allergo J 2002; 11: 332-8
76. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000; 106: E8
77. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, Storms WW, Wood RA. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000; 105: E23
78. Statistisches Bundesamt. Gesundheitsbericht für Deutschland. Spezialbericht Allergien. Stuttgart: Metzler-Poeschel, 2000.
79. Vuurman EF, Veggel LM van, Uiterwijk MM, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993; 71: 121-6
80. Weck AL de. Diagnostic approaches to allergy. Int Arch Allergy Immunol 1993; 101: 346-51
81. Weiser M, Gegenheimer LH, Klein P. A randomized equivalence trial comparing the efficacy and safety of Luffa comp.-Heel nasal spray with cromolyn sodium spray in the treatment of seasonal allergic rhinitis. Forsch Komplementarmed 1999; 6: 142-8
82. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001; 31: 61-8
83. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994; 94: 895-901
84. Xue CC, English R, Zhang JJ, Da Costa C, Li CG. Effect of acupuncture in the treatment of seasonal allergic rhinitis: a randomized controlled clinical trial. Am J Chin Med 2002; 30: 1-11